NO941036L - Sparfloxacinsalter og opplösninger inneholdende saltene - Google Patents

Sparfloxacinsalter og opplösninger inneholdende saltene

Info

Publication number
NO941036L
NO941036L NO941036A NO941036A NO941036L NO 941036 L NO941036 L NO 941036L NO 941036 A NO941036 A NO 941036A NO 941036 A NO941036 A NO 941036A NO 941036 L NO941036 L NO 941036L
Authority
NO
Norway
Prior art keywords
sparfloxacin
salts
monocarboxylic
pharmaceutically acceptable
solutions containing
Prior art date
Application number
NO941036A
Other languages
English (en)
Other versions
NO941036D0 (no
Inventor
Guillaume Conrath
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of NO941036D0 publication Critical patent/NO941036D0/no
Publication of NO941036L publication Critical patent/NO941036L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

Farmasøytisk preparat bestående av en stabil vandig oppløsning av sparfloxacin med formelen: inneholdende sparfloxacin, - en eller flere monokarboksyliske polyhydroksysyrer eller dereslaktonderivater, i det minste i støklo- metrisk mengde i forhold til sparfloxacin, hvis nødvendig, et overskudd av monokarboksylisk polyhydroksysyre eller en annen farmasøytisk aksepterbar syre, ment for å sikre en pH-verdi som tillater fullstendig oppløseliggjøring av det således dannede salt, > 5, og - eventuelt et isotoniserende middel og/eller andre farmasøytisk akseptable hjelpestoffer.
NO941036A 1991-09-27 1994-03-22 Sparfloxacinsalter og opplösninger inneholdende saltene NO941036L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9111913A FR2681863B1 (fr) 1991-09-27 1991-09-27 Solution de sparfloxacine sa preparation et sel la constituant.
PCT/FR1992/000891 WO1993005782A1 (fr) 1991-09-27 1992-09-25 Sels de sparfloxacine et solutions les contenant

Publications (2)

Publication Number Publication Date
NO941036D0 NO941036D0 (no) 1994-03-22
NO941036L true NO941036L (no) 1994-03-22

Family

ID=9417358

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941036A NO941036L (no) 1991-09-27 1994-03-22 Sparfloxacinsalter og opplösninger inneholdende saltene

Country Status (22)

Country Link
US (1) US5478829A (no)
EP (2) EP0534860A1 (no)
JP (1) JPH07503941A (no)
AT (1) ATE168008T1 (no)
AU (1) AU671602B2 (no)
CA (1) CA2119270A1 (no)
CZ (1) CZ69494A3 (no)
DE (1) DE69226192D1 (no)
FI (1) FI941399A0 (no)
FR (1) FR2681863B1 (no)
HU (1) HUT67672A (no)
IL (1) IL103270A (no)
MX (1) MX9205461A (no)
NO (1) NO941036L (no)
NZ (1) NZ244479A (no)
PL (2) PL170495B1 (no)
SG (1) SG59982A1 (no)
SK (1) SK34894A3 (no)
TW (1) TW202393B (no)
WO (1) WO1993005782A1 (no)
YU (1) YU86792A (no)
ZA (1) ZA927330B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
EP1685843A1 (en) * 1999-06-30 2006-08-02 Ruey J. Dr. Yu Oligosaccharide aldonic acids and their topical use
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE19962353A1 (de) 1999-12-23 2001-07-05 Henkel Ecolab Gmbh & Co Ohg Hepatitis A Viruzid
US6979471B1 (en) * 2000-09-05 2005-12-27 Council Of Scientific And Industrial Research Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
WO2003015752A1 (en) * 2001-08-14 2003-02-27 Bakulesh Mafatlal Khamar The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
EP2712611A1 (en) * 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤

Also Published As

Publication number Publication date
NO941036D0 (no) 1994-03-22
EP0605646B1 (fr) 1998-07-08
HU9400868D0 (en) 1994-06-28
US5478829A (en) 1995-12-26
FI941399A (fi) 1994-03-25
FI941399A0 (fi) 1994-03-25
AU2772292A (en) 1993-04-27
ATE168008T1 (de) 1998-07-15
CZ69494A3 (en) 1994-07-13
PL170495B1 (en) 1996-12-31
FR2681863B1 (fr) 1995-02-03
DE69226192D1 (de) 1998-08-13
IL103270A0 (en) 1993-02-21
PL170357B1 (en) 1996-12-31
EP0605646A1 (fr) 1994-07-13
MX9205461A (es) 1993-03-01
HUT67672A (en) 1995-04-28
TW202393B (no) 1993-03-21
ZA927330B (en) 1993-04-21
FR2681863A1 (fr) 1993-04-02
IL103270A (en) 1996-11-14
WO1993005782A1 (fr) 1993-04-01
CA2119270A1 (fr) 1993-04-01
SG59982A1 (en) 1999-02-22
NZ244479A (en) 1995-04-27
EP0534860A1 (fr) 1993-03-31
JPH07503941A (ja) 1995-04-27
AU671602B2 (en) 1996-09-05
YU86792A (sh) 1995-10-03
SK34894A3 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
NO941036D0 (no) Sparfloxacinsalter og opplösninger inneholdende saltene
AU563777B2 (en) Piperazine-quinoline derivatives in basic aqueous pharmaceutical preparations
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DK72289A (da) Cephemcarboxylsyreestere, deres fremstilling og anvendelse
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
FI902900A0 (fi) Menetelmä kiteisten kefeemihappoadditiosuolojen valmistamiseksi
ATE127343T1 (de) Pharmazeutische zubereitung von roxindol oder carmoxirol mit vorgeqüollener stärke.
RU94019970A (ru) Водный раствор спарфлоксацина, способ его получения и соль спарфлоксацина и фармацевтическая композиция
DK0390099T3 (da) Polære cephalosporinderivater og fremgangsmåde til deres fremstilling